BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells Luca Mologni, Silvia Truffa, et al. Mol Cancer Res 2008;6:751-759
PLX4032, a selective BRAF V600E kinase inhibitor,activates the ERK pathway and enhances cell migration and proliferation of BRAF WT melanoma cells Ruth Halaban,Wengeng Zhang,et al. Pigment Cell Melanoma Res 2010;23; 190–200
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.